← Return to Anyone on Pluvicto (Lu 177), a new drug for prostate cancer?

Discussion

Anyone on Pluvicto (Lu 177), a new drug for prostate cancer?

Prostate Cancer | Last Active: Feb 27 9:46am | Replies (171)
Comment receiving replies
@cjbbjc2010

Can anyone give feedback on how Pluvicto treatment response is being determined? is it MRI, CT, a PSMA PET scan with F-18 or G-68 agent? If with PSMA PET, has insurance been covering it? Cost is a concern. thanks

Jump to this post

Replies to "Can anyone give feedback on how Pluvicto treatment response is being determined? is it MRI, CT,..."
rrosberg1 | @rrosberg1 | Sep 26, 2023

Had PSMA rejected by Aetna twice. After several appeals they approved it. The back story was $$$. The hospital where it was scheduled was going to charge approx. $18K. After I shopped around a private oncology center quoted me less than $6K. The approval was given after the hospital agreed to approx. this amount. My inquires indicate that Aetna was slow on approving other things. I moved to United.

VIEW AND REPLY